SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-144628
Filing Date
2016-09-14
Accepted
2016-09-14 16:12:59
Documents
54
Period of Report
2016-07-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-16397_110q.htm 10-Q 876540
2 EX-31.1 a16-16397_1ex31d1.htm EX-31.1 9349
3 EX-31.2 a16-16397_1ex31d2.htm EX-31.2 9070
4 EX-32.1 a16-16397_1ex32d1.htm EX-32.1 6870
  Complete submission text file 0001104659-16-144628.txt   4051410

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bpmx-20160731.xml EX-101.INS 749949
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bpmx-20160731.xsd EX-101.SCH 33907
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bpmx-20160731_cal.xml EX-101.CAL 38212
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bpmx-20160731_def.xml EX-101.DEF 169252
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bpmx-20160731_lab.xml EX-101.LAB 316892
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bpmx-20160731_pre.xml EX-101.PRE 281224
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 161885230
SIC: 2834 Pharmaceutical Preparations